Muenchenstein, Switzerland

Hans-Peter Brunner

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Innovations by Inventor Hans-Peter Brunner

Introduction

Hans-Peter Brunner is an innovative inventor based in Muenchenstein, Switzerland. He has made significant contributions to the medical field, particularly in heart failure treatment and diagnostics. With a total of five patents, his research focuses on enhancing patient care and monitoring through advanced biomarkers.

Latest Patents

Among his recent inventions are two notable patents. The first patent addresses "Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides." This invention discloses methods for identifying patients who could benefit from intensified heart failure therapy. It relies on measuring levels of specific markers in patients undergoing B-type natriuretic peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP)-guided therapy. Additionally, kits and devices designed to implement these methods are also included.

The second patent involves "IGFBP7 for diagnosing diastolic dysfunction." This method facilitates diagnosis and grading of diastolic dysfunction or related abnormalities by measuring IGFBP7 levels in heart failure patients and comparing them to reference levels. This approach not only aids in diagnosis but also provides a framework for monitoring diastolic function. Similar to his first patent, kits and devices for the application of these methods are also described.

Career Highlights

Hans-Peter Brunner currently works at Roche Diagnostics Operations, Inc., a leader in medical diagnostics. His innovative work has contributed to the development of diagnostics that significantly improve patient outcomes in cardiology.

Collaborations

Throughout his career, Brunner has collaborated with esteemed colleagues such as Dirk Block and Ursula-Henrike Wienhues-Thelen. These collaborations reflect a robust network of professionals dedicated to advancing healthcare solutions.

Conclusion

With five patents to his name, Hans-Peter Brunner exemplifies the spirit of innovation in the medical field. His work on biomarkers for heart failure opens new avenues for patient assessment and treatment, showcasing his commitment to improving health outcomes. As he continues to develop groundbreaking technologies, the impact of his contributions will undoubtedly resonate in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…